1888 PressRelease Home	Sign In	Register	About Us	Sitemap

1888 Press Release | Ocucure Press Releases

Ocucure.com - Ocucure Company News Section

Ocucure Information

J Wade

URL: http://www.ocucure.com

xOcuCure Therapeutics is a biopharmaceutical company, formed in August 2005 based on initial drug discovery research supported by the Carilion Biomedical Institute. The Companyâ€™s lead compound, OC-10X, targets Age-related Macular Degeneration (AMD), the leading cause of blindness in developed countries, and diabetic retinopathy (DR), the leading cause of blindness in the U.S. among adults age 24-70.

Ocucure Press Release -

Ocucure.com

14
JUL

OcuCure Therapeutics Ophthalmic Lead Compound for AMD Demonstrates Robust Efficacy in Primates Major advancement in AMD therapeutic landscape

OcuCure Therapeutics, Inc. is an ophthalmic pharmaceutical company developing new proprietary drugs. The company’s lead compound has been formulated as a topical eye drop for both Age-related Macular Degeneration (AMD) and Diabetic Retinopathy (DR). AMD and DR are leading causes of blindness in developed countries. Additionally, the lead compound has potential for use as a prophylactic.

OcuCure Therapeutics, Inc., a biopharmaceutical company specializing in the treatment of eye disease, reported final results from primate testing of i ...